Amarin Corporation plc
AMRN
Rank in Stocks
#15811
Amarin Corporation plc is a pharmaceutical firm dedicated to the research,... Amarin Corporation plc is a pharmaceutical firm dedicated to the research, development, and commercialization of therapeutic solutions for cardiovascular diseases. Its operations span several international regions, including the United States, Germany, Canada, Lebanon, and the United Arab Emirates. The company's flagship product is VASCEPA, an omega-3 fatty acid formulation available by prescription only. This medication acts as an adjunctive therapy to diet, designed to decrease elevated triglyceride levels in adult patients suffering from severe hypertriglyceridemia. Amarin primarily distributes its offerings through wholesale channels and specialized pharmacy providers. Furthermore, the company has entered into a collaboration with Mochida Pharmaceutical Co., Ltd. to advance the development and market introduction of drug products and new indications derived from Vascepa's active pharmaceutical ingredient, which encompasses omega-3 acid and eicosapentaenoic acid. Established in 1989 as Ethical Holdings plc, the organization rebranded to Amarin Corporation plc in 1999. Its corporate headquarters are located in Dublin, Ireland.
Share Price
$11.74
Last synced: 2026-11-09
Market Cap
$242.82M
Change (1 day)
1.12%
Change (1 year)
-27.04%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Amarin Corporation plc (AMRN)
Category
Healthcare
EPS for Amarin Corporation plc (AMRN)
EPS as of September 2026 TTM: $-1.05
According to Amarin Corporation plc's latest financial reports, its current EPS (TTM) is $-1.05. At the end of 2025 the company had an EPS of $-1.80, an increase over its 2024 EPS of $-4.00.
EPS history for Amarin Corporation plc from 2000 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-1.05 | -41.67% |
| 2025 | $-1.80 | -55.00% |
| 2024 | $-4.00 | 33.33% |
| 2023 | $-3.00 | -42.31% |
| 2022 | $-5.20 | -1,433.33% |
| 2021 | $0.39 | -141.31% |
| 2020 | $-0.94 | -28.59% |
| 2019 | $-1.32 | -83.05% |
| 2018 | $-7.80 | 56.00% |
| 2017 | $-5.00 | -39.02% |
| 2016 | $-8.20 | -50.60% |
| 2015 | $-16.60 | 159.38% |
| 2014 | $-6.40 | -68.93% |
| 2013 | $-20.60 | -16.94% |
| 2012 | $-24.80 | 133.96% |
| 2011 | $-10.60 | -78.71% |
| 2010 | $-49.80 | 77.86% |
| 2009 | $-28.00 | 53.85% |
| 2008 | $-18.20 | -77.70% |
| 2007 | $-81.60 | 21.79% |
| 2006 | $-67.00 | -27.65% |
| 2005 | $-92.60 | -369.19% |
| 2004 | $34.40 | -115.30% |
| 2003 | $-224.80 | -71.79% |
| 2002 | $-796.80 | 687.35% |
| 2001 | $-101.20 | -178.82% |
| 2000 | $128.40 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -1,591.43% |
US
|
|
| $-7.07 | 573.33% |
US
|
|
| $-5.29 | 403.81% |
AU
|
|
| $12.88 | -1,326.68% |
BE
|
|
| $21.56 | -2,153.33% |
NL
|
Questions about Amarin Corporation plc's earnings per share (EPS)
What is Amarin Corporation plc's earnings per share (EPS)?
Amarin Corporation plc's earnings per share (EPS) over the last twelve months is $-1.05, as of Sep 2026.
What was Amarin Corporation plc's earnings per share (EPS) in 2025?
In 2025, Amarin Corporation plc's earnings per share (EPS) was $-1.80, compared with $-4.00 in 2024.
How has Amarin Corporation plc's earnings per share (EPS) changed since 2020?
From 2020 to 2025, Amarin Corporation plc's earnings per share (EPS) was highest in 2021 ($0.39) and lowest in 2022 ($-5.20).
How does Amarin Corporation plc's earnings per share (EPS) compare with similar companies?
Amarin Corporation plc's earnings per share (EPS) ($-1.05) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.